58-37-109. Listed controlled substances.

288 words·~1 min read·/ut/title-58/chapter-37/58-37-109

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

Effective 5/6/2026

The following substances, their analogs, homologs, and synthetic equivalents, are listed controlled substances:

(1)AB-001;

(2)AB-PINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-pentyl-1H-indazole-3-carboxamide;

(3)AB-FUBINACA; N-[1-(aminocarbonyl)-2-methylpropyl]-1-[(4-fluorophenyl) methyl]-1H-indazole-3-carboxamide;

(4)AB-CHMINACA (N-(1-Amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);

(5)ADB-CHMINACA (N-[(2S)-1-amino-3,3-dimethyl-1-oxobutan-2-yl]-1- (cyclohexylmethyl)indazole-3-carboxamide);

(6)ADB-FUBINACA (N-(1-amino-3,3-dimethyl-1oxobutan-2-yl)-1- (4-fluorobenzyl)-1H-indazole-3-caboxamide);

(7)AKB48;

(8)alpha-Pyrrolidinohexanophenone (alpha-PHP) (1-Phenyl-2-(pyrrolidin-1-yl)hexan-1-one);

(9)alpha-Pyrrolidinovalerophenone (alpha-PVP);

(10)AM-694 (1-[(5-fluoropentyl)-1H-indol-3-yl]-(2-iodophenyl)methanone);

(11)AM-1248;

(12)AM-2201 (1-(5-fluoropentyl)-3-(1-naphthoyl)indole);

(13)AM-2233;

(14)AM-679;

(15)A796,260;

(16)Butylone;

(17)CP 47,497 and its C6, C8, and C9 homologs (2-[(1R,3S)-3-hydroxycyclohexyl] -5-(2-methyloctan-2-yl)phenol);

(18)Diisopropyltryptamine (DiPT);

(19)Ethylone;

(20)Ethylphenidate;

(21)Fluoroisocathinone;

(22)Fluoromethamphetamine;

(23)Fluoromethcathinone;

(24)FUB-AMB; methyl (1-(4-fluorobenzyl)-1H-indazole-3-carbonyl)valinate;

(25)HU-210; (6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl) -6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(26)HU-211; Dexanabinol,(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-

methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol;

(27)JWH-015; (2-methyl-1-propyl-1H-indol-3-yl)-1-naphthalenyl-methanone;

(28)JWH-018; Naphthalen-1-yl-(pentylindol-3-yl)methanone {also known as 1-Pentyl-3-(1-naphthoyl)indole};

(29)JWH-019; 1-hexyl-3-(1-naphthoyl)indole;

(30)JWH-073; Naphthalen-1-yl(1-butylindol-3-yl)methanone {also known as 1-Butyl-3-(1-naphthoyl)indole};

(31)JWH-081; 4-methoxynaphthalen-1-yl-(1-pentylindol-3-yl)methanone;

(32)JWH-122; CAS#619294-47-2; (1-Pentyl-3-(4-methyl-1-naphthoyl)indole);

(33)JWH-200; 1-(2-(4-(morpholinyl)ethyl))-3-(1-naphthoyl)indole;

(34)JWH-203; 1-pentyl-3-(2-chlorophenylacetyl)indole;

(35)JWH-210; 4-ethyl-1-naphthalenyl(1-pentyl-1H-indol-3-yl)-methanone;

(36)JWH-250; 1-pentyl-3-(2-methoxyphenylacetyl)indole;

(37)JWH-251; 2-(2-methylphenyl)-1-(1-pentyl-1H-indol-3-yl)ethanone;

(38)JWH-398; 1-pentyl-3-(4-chloro-1-naphthoyl)indole;

(39)MAM-2201;

(40)MAM-2201; (1-(5-fluoropentyl)-1H-indol-3-yl)(4-ethyl-1-naphthalenyl)-methanone;

(41)Methoxetamine;

(42)Naphyrone;

(43)PB-22; 1-pentyl-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(44)Pentedrone;

(45)Pentylone;

(46)RCS-4; 1-pentyl-3-(4-methoxybenzoyl)indole;

(47)RCS-8; 1-(2-cyclohexylethyl)-3-(2-methoxyphenylacetyl)indole {also known as BTW-8 and SR-18};

(48)STS-135;

(49)UR-144;

(50)UR-144 N-(5-chloropentyl) analog;

(51)XLR11;

(52)2C-C;

(53)2C-D;

(54)2C-E;

(55)2C-H;

(56)2C-I;

(57)2C-N;

(58)2C-P;

(59)2C-T-2;

(60)2C-T-4;

(61)2NE1;

(62)25I-NBOMe;

(63)2,5-Dimethoxy-4-chloroamphetamine (DOC);

(64)4-Fluoro MDMB-BUTINACA (Methyl 2-(1-(4-fluorobutyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate);

(65)4-methylmethcathinone {also known as mephedrone};

(66)3,4-methylenedioxypyrovalerone {also known as MDPV};

(67)3,4-Methylenedioxymethcathinone {also known as methylone};

(68)4-methoxymethcathinone;

(69)4-Methyl-alpha-pyrrolidinopropiophenone;

(70)4-Methylethcathinone;

(71)5F-AKB48; 1-(5-flouropentyl)-N-tricyclo[3.3.1.13,7]dec-1-yl-1H-indazole-3- carboxamide;

(72)5-Fluoro ADB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}-3-methyl-valinate);

(73)5-Fluoro AMB (Methyl N-{[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}valinate);

(74)5-fluoro-PB-22; 1-(5-fluoropentyl)-1H-indole-3-carboxylic acid 8-quinolinyl ester;

(75)5-Iodo-2-aminoindane (5-IAI);

(76)5-MeO-DALT;

(77)25B-NBOMe; 2-(r-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine;

(78)25C-NBOMe; 2-(4Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl) methyl]ethanamine; and

(79)25H-NBOMe; 2-(2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine.

Renumbered and Amended by Chapter 362 , 2026 General Session